SANA'A June 8 . 2024 (Saba) -Disastrous repercussions caused by the aggression and blockade on the pharmaceutical sector in Yemen as a result of the closure of Sana’a International Airport and the prevention of the entry of medicines, which caused the death of thousands of patients, especially those suffering from chronic diseases such as “kidney failure, kidney transplants, cancer, diabetes, heart, and thalassemia” who were receiving medicines. From the Ministry of Public Health and Population.
In contrast to the great challenges that this sector faced over the past years, this sector has witnessed unremitting efforts to develop local pharmaceutical industries to provide the country’s needs for necessary medicines and mitigate the repercussions of the aggression and blockade that caused suffering and a humanitarian catastrophe for Yemeni people, especially patients for whom obtaining medicine is essential to continue their lives.
The pharmaceutical industry and achieving drug security are the top priorities of the Revolutionary Leadership and the Supreme Political Council, given the systematic targeting of this vital sector by the aggression and its repercussions that led to a shortage of medicine.
Currently, the pharmaceutical industry is receiving more attention and development and harnessing the necessary capabilities to develop scientific research and innovation in a way that contributes to improving the pharmaceutical industry and increasing the number of its types through preparing a map of health project priorities and establishing areas for pharmaceutical industries, and a guide for investments in the health sector, which would create a safe medicine accessible to everyone.
In light of the interest of the state and the government in the pharmaceutical industry sector, the appropriate climate was created to build national pharmaceutical industries that guarantee the achievement of pharmaceutical security, which was emphasized by Mahdi Al-Mashat, Chairman of the Supreme Political Council, regarding the necessity of localizing the pharmaceutical industries in the country.
During his meeting with the Minister of Public Health and Population in the caretaker government, Dr. Taha Al-Mutawakkil, and the leadership of the Pharmaceutical Manufacturers Union last August, His Excellency the President directed the creation of a strategic plan to localize the pharmaceutical industries. He said, “We will present a list of incentives to localize pharmaceutical manufacturing, and you will find advantages and incentives that will please you as investors in This is the medical field.
President Al-Mashat also directed the Ministers of Finance, Industry and Health to study all the problems and obstacles facing the investment process in the health sector and work to solve them and provide a package of facilities in this important aspect.
At its last meeting, the Council of Ministers approved the draft law on medicine and pharmacy submitted by the Minister of Health, which consists of ten chapters that include nomenclature, definitions and objectives, medicine, narcotic substances, psychotropic substances and chemical precursors, national pharmaceutical industries, pharmaceutical media, pharmacy, control and inspection, penalties, and final provisions.
The project aims to regulate the processes of registration, import, manufacture, distribution, and circulation of medicine, and to ensure the safety, quality, effectiveness, and safety of medicine and any other materials stipulated in the law, as well as the rational use of medicine, and to regulate the prescription, dispensing, and sale of medicine or any other products stipulated in the law and to protect the individual and society from harm. Damage and dangers resulting from misuse or taking of medicine or from counterfeit medicines or narcotic substances and psychotropic substances, as well as encouraging and developing national pharmaceutical industries.
At its meeting, the government also approved a draft law for conducting clinical pharmaceutical studies submitted by the Minister of Health, which consists of five chapters that include nomenclature and definitions, general objectives and general provisions, the competent research committee, the pharmaceutical studies committee, penalties and final provisions.
The draft law was designed to achieve a number of goals, including establishing the foundations, standards, and controls for conducting therapeutic and non-therapeutic drug studies, and organizing and directing these studies in a way that maintains the safety and security of their participants, as well as protecting participants (volunteers or patients) in this type of study.
This comes in light of the Ministry of Health’s endeavor to strengthen the partnership between the public and private sectors to achieve achievements in the pharmaceutical industries in line with the achievements achieved by the wisdom of the revolutionary leadership and the Supreme Political Council in a number of fields.
The Minister of Public Health in the caretaker government, Dr. Taha Al-Mutawakkil, confirmed that there are unremitting efforts to implement a number of policies aimed at achieving drug security and developing the national industry in the field of medicine and medical supplies.
He pointed out that the pharmaceutical industry is witnessing remarkable development represented by the construction of many factories, with the aim of developing the local pharmaceutical industry and reducing the import bill.
He noted that despite the challenges facing the health sector, work was done and benefited from the blockade in moving towards the local pharmaceutical industry to achieve pharmaceutical security and achieve self-sufficiency.
Minister Al-Mutawakkil pointed to the direction of the revolutionary leadership and the Supreme Political Council to build the nation in various fields, especially in the health and pharmaceutical sector, achieve self-sufficiency in medicine, benefit from local resources, plants and medicinal rocks in the production process, and overcome the conditions imposed by the aggression and siege.
He also stressed the keenness to strengthen partnerships and encourage investment in local pharmaceutical industries, considering this a national and humanitarian responsibility to solve many issues and meet needs. He stressed that it was announced during the last period about the localization of a thousand types of pharmaceutical products.
The Ministry of Health is making great efforts to move towards the pharmaceutical industry through the Supreme Authority for Pharmaceuticals and Medical Supplies. A report issued by the Ministry, a copy of which was received by the Yemeni News Agency (Saba), stated that the Authority has prepared its regulatory regulations and the Pharmacy and Medicines Law, with 10 regulations having been completed. Issuing the drug policy for the next ten years, and updating the list of essential medicines.
The report indicated that companies were organized and registered in a way that enhances the provision of medicines to the citizen and breaks the monopoly, restricting 66 types to the local industry, issuing a decision to localize a thousand types during the next five years, stimulating the local industry and constructing three new factories within the plan to reach 12 factories, and receiving 20 applications to establish New pharmaceutical factories, as well as receiving a request for the first time to establish a medical supplies factory.
He stated that 38 drug production lines were built during the current year and will reach 48, the number of locally manufactured items is 1,818, and the number of new laboratories is 15. 500 million riyals were disbursed to Yedco to manufacture intravenous solutions, and a comprehensive survey was conducted of areas that had been surveyed previously to explore and inventory medicinal herbs in the country.
The report explained that a comprehensive guide to medicinal plants was prepared, 15 natural plants were identified for cultivation and propagation, 40 HPLC testing devices and the rest of the priority devices were purchased for drug testing, and the provision of two GC and GC-MAS devices (modern for the first time in Yemen) at a value of $814,000. Restoring the old laboratory and starting the rehabilitation of the new pharmaceutical laboratory at a value of two billion and 800 million riyals, completing the automation in the Authority and the outlets, pricing three thousand and 700 traded items in an application, and following up on pricing and descending to monitor companies and items.
The authority has established five national pharmacies in the capital Sana'a, and work is continuing to complete the rest of the governorates, providing medicines for patients with chronic diseases, and specific medicines such as albumin and growth hormone, and providing three million insulin vials worth 22 million dollars.
Medicines for blood diseases, genetic diseases, and hemophilia worth $15 million were also provided, as well as medicines for immune diseases, kidney and organ transplants, multiple sclerosis, diphtheria serum, and basic medicines, as well as medicines for centers and units to more than two thousand facilities, for a total of more than 25 billion riyals.
M.M
In contrast to the great challenges that this sector faced over the past years, this sector has witnessed unremitting efforts to develop local pharmaceutical industries to provide the country’s needs for necessary medicines and mitigate the repercussions of the aggression and blockade that caused suffering and a humanitarian catastrophe for Yemeni people, especially patients for whom obtaining medicine is essential to continue their lives.
The pharmaceutical industry and achieving drug security are the top priorities of the Revolutionary Leadership and the Supreme Political Council, given the systematic targeting of this vital sector by the aggression and its repercussions that led to a shortage of medicine.
Currently, the pharmaceutical industry is receiving more attention and development and harnessing the necessary capabilities to develop scientific research and innovation in a way that contributes to improving the pharmaceutical industry and increasing the number of its types through preparing a map of health project priorities and establishing areas for pharmaceutical industries, and a guide for investments in the health sector, which would create a safe medicine accessible to everyone.
In light of the interest of the state and the government in the pharmaceutical industry sector, the appropriate climate was created to build national pharmaceutical industries that guarantee the achievement of pharmaceutical security, which was emphasized by Mahdi Al-Mashat, Chairman of the Supreme Political Council, regarding the necessity of localizing the pharmaceutical industries in the country.
During his meeting with the Minister of Public Health and Population in the caretaker government, Dr. Taha Al-Mutawakkil, and the leadership of the Pharmaceutical Manufacturers Union last August, His Excellency the President directed the creation of a strategic plan to localize the pharmaceutical industries. He said, “We will present a list of incentives to localize pharmaceutical manufacturing, and you will find advantages and incentives that will please you as investors in This is the medical field.
President Al-Mashat also directed the Ministers of Finance, Industry and Health to study all the problems and obstacles facing the investment process in the health sector and work to solve them and provide a package of facilities in this important aspect.
At its last meeting, the Council of Ministers approved the draft law on medicine and pharmacy submitted by the Minister of Health, which consists of ten chapters that include nomenclature, definitions and objectives, medicine, narcotic substances, psychotropic substances and chemical precursors, national pharmaceutical industries, pharmaceutical media, pharmacy, control and inspection, penalties, and final provisions.
The project aims to regulate the processes of registration, import, manufacture, distribution, and circulation of medicine, and to ensure the safety, quality, effectiveness, and safety of medicine and any other materials stipulated in the law, as well as the rational use of medicine, and to regulate the prescription, dispensing, and sale of medicine or any other products stipulated in the law and to protect the individual and society from harm. Damage and dangers resulting from misuse or taking of medicine or from counterfeit medicines or narcotic substances and psychotropic substances, as well as encouraging and developing national pharmaceutical industries.
At its meeting, the government also approved a draft law for conducting clinical pharmaceutical studies submitted by the Minister of Health, which consists of five chapters that include nomenclature and definitions, general objectives and general provisions, the competent research committee, the pharmaceutical studies committee, penalties and final provisions.
The draft law was designed to achieve a number of goals, including establishing the foundations, standards, and controls for conducting therapeutic and non-therapeutic drug studies, and organizing and directing these studies in a way that maintains the safety and security of their participants, as well as protecting participants (volunteers or patients) in this type of study.
This comes in light of the Ministry of Health’s endeavor to strengthen the partnership between the public and private sectors to achieve achievements in the pharmaceutical industries in line with the achievements achieved by the wisdom of the revolutionary leadership and the Supreme Political Council in a number of fields.
The Minister of Public Health in the caretaker government, Dr. Taha Al-Mutawakkil, confirmed that there are unremitting efforts to implement a number of policies aimed at achieving drug security and developing the national industry in the field of medicine and medical supplies.
He pointed out that the pharmaceutical industry is witnessing remarkable development represented by the construction of many factories, with the aim of developing the local pharmaceutical industry and reducing the import bill.
He noted that despite the challenges facing the health sector, work was done and benefited from the blockade in moving towards the local pharmaceutical industry to achieve pharmaceutical security and achieve self-sufficiency.
Minister Al-Mutawakkil pointed to the direction of the revolutionary leadership and the Supreme Political Council to build the nation in various fields, especially in the health and pharmaceutical sector, achieve self-sufficiency in medicine, benefit from local resources, plants and medicinal rocks in the production process, and overcome the conditions imposed by the aggression and siege.
He also stressed the keenness to strengthen partnerships and encourage investment in local pharmaceutical industries, considering this a national and humanitarian responsibility to solve many issues and meet needs. He stressed that it was announced during the last period about the localization of a thousand types of pharmaceutical products.
The Ministry of Health is making great efforts to move towards the pharmaceutical industry through the Supreme Authority for Pharmaceuticals and Medical Supplies. A report issued by the Ministry, a copy of which was received by the Yemeni News Agency (Saba), stated that the Authority has prepared its regulatory regulations and the Pharmacy and Medicines Law, with 10 regulations having been completed. Issuing the drug policy for the next ten years, and updating the list of essential medicines.
The report indicated that companies were organized and registered in a way that enhances the provision of medicines to the citizen and breaks the monopoly, restricting 66 types to the local industry, issuing a decision to localize a thousand types during the next five years, stimulating the local industry and constructing three new factories within the plan to reach 12 factories, and receiving 20 applications to establish New pharmaceutical factories, as well as receiving a request for the first time to establish a medical supplies factory.
He stated that 38 drug production lines were built during the current year and will reach 48, the number of locally manufactured items is 1,818, and the number of new laboratories is 15. 500 million riyals were disbursed to Yedco to manufacture intravenous solutions, and a comprehensive survey was conducted of areas that had been surveyed previously to explore and inventory medicinal herbs in the country.
The report explained that a comprehensive guide to medicinal plants was prepared, 15 natural plants were identified for cultivation and propagation, 40 HPLC testing devices and the rest of the priority devices were purchased for drug testing, and the provision of two GC and GC-MAS devices (modern for the first time in Yemen) at a value of $814,000. Restoring the old laboratory and starting the rehabilitation of the new pharmaceutical laboratory at a value of two billion and 800 million riyals, completing the automation in the Authority and the outlets, pricing three thousand and 700 traded items in an application, and following up on pricing and descending to monitor companies and items.
The authority has established five national pharmacies in the capital Sana'a, and work is continuing to complete the rest of the governorates, providing medicines for patients with chronic diseases, and specific medicines such as albumin and growth hormone, and providing three million insulin vials worth 22 million dollars.
Medicines for blood diseases, genetic diseases, and hemophilia worth $15 million were also provided, as well as medicines for immune diseases, kidney and organ transplants, multiple sclerosis, diphtheria serum, and basic medicines, as well as medicines for centers and units to more than two thousand facilities, for a total of more than 25 billion riyals.
M.M
resource : SABA